TagsInternal medicine 
Are We Doing Our Best to Reduce the Risk of HCC in HBV Patients?

Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death worldwide. Essentially, persistent hepatitis B virus (HBV) infection is one of the most important risk factors for HCC1. Thus, targeted strategies to mitigate HBV ...

Feb 17, 2025
Thriving Beyond the Challenges of Multiple Myeloma Post- Transplantation

Multiple myeloma (MM) is a clonal plasma cell disorder characterised by excess production of monoclonal immunoglobulins and light chains that can ultimately lead to specific end-organ damage 1 . Notably, MM is the second most common haematologic mal...

Oct 22, 2024
The Unmet Needs in Relapse/ Refractory Multiple Myeloma: A Clinical Challenge

Multiple myeloma (MM) is a haematologic malignancy characterised by abnormal clonal plasma cells in the bone marrow with a potential for uncontrolled growth causing destruction, osseous lesion, acute kidney injury (AKI), anaemia, and hypercalcaemia....

Aug 20, 2024